Neuberger Berman Canada’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-15
Closed -$1K 275
2016
Q3
$1K Buy
+15
New +$1.94K ﹤0.01% 192

Other funds holding ELV

Neuberger Berman Canada's ELV Position: Q3 2017 in Review

Neuberger Berman Canada reduced its Elevance Health (ELV) stake by 4.7% in Q3 2017, selling an estimated $65.7K and leaving 7,005 shares worth $1.33M. The position accounts for 0.25% of the portfolio, ranked #102.

Neuberger Berman Canada first reported a position in ELV in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.51M in Q3 2014. 844 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • Neuberger Berman Canada held 7,005 shares of Elevance Health worth $1.33M as of Q3 2017.
  • Neuberger Berman Canada sold 345 Elevance Health shares in Q3 2017, an estimated $65.7K.
  • Elevance Health made up 0.25% of Neuberger Berman Canada's portfolio in Q3 2017, its #102 holding.
  • Neuberger Berman Canada first reported a position in Elevance Health in Q2 2013 and has held it in 18 quarters since.
  • Neuberger Berman Canada's Elevance Health position peaked at $3.51M in Q3 2014.
  • 844 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.